Home
Insights

Henrik Stender

Board Member at Visiopharm

Board member Dr. Stender is owner of Stender Diagnostics, which specializes in the transition of innovative research technologies into commercial in vitro diagnostic (IVD) products. As co-founder of AdvanDx he served as VP of Research & Development until 2011. Prior to AdvanDx, Dr. Stender was Director of Microbiology at Boston Probes, which was acquired by Applied Biosystems in 2001. Before joining Boston Probes in 1998, he was project manager at DAKO and inventor of the first PNA-based test for infectious diseases. Dr. Stender has 20 years of experience with all aspects of developing diagnostic test kits. He has spearheaded the transition of the PNA technology from an academic curiosity to powerful diagnostic tools with documented improvements in patient care supported by numerous FDA clearances, patents, publications in scientific journals and presentations at international meetings. Dr. Stender holds a M.Sc. in chemical engineering and a Ph.D. in immunology, both from the Technical University of Denmark, and he received his Bachelor degree in commerce from Copenhagen Business School.

Roles

  • Board Member

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.